Kwyn VanDyke

Promotion to Executive sales level

• Represent Eisai Oncology product portfolio for Endometrial, Differentiated Thyroid Cancer, Hepatocellular Cancer and Breast Cancer by targeting Oncology offices, Gynecological Oncology, hospitals, and specialty pharmacies in Detroit, Ann Arbor, Grand Rapids, Kalamazoo, Muskegon, Holland, Lansing, Traverse City, St. Joseph, and Toledo, OH regions
• 2023 Ranked #3 in nation - Circle of Excellence Award winner (top 10%)
• 2023 #1 in Nation - Pinnacle Team Award Winner (top team in region)
• 2023 - Long Term incentive award winner (top 25%)
• 2021 - Long Term incentive award winner (top 25%)
• Launch new indication for Lenvima (lenvatinib) in combination with immunotherapy, Keytruda (pembrolizumab), in the EC market
• Appointed to Access and Reimbursement Advisory Board and MSHO representative, Compliance Advisory Board, Eisai mento5ring program and EC Marketing Field Advisory Board
• Collaborate with Eisai partners and personnel to service all the office's needs
• Also collaborate with corporate partners, Merck representatives, for combination indication with Keytruda immunotherapy combination
• Promotion of Halaven for Breast Cancer

• Exceeded growth goals (top 25% of sales)
• Represent Novartis Oncology Business Unit in the Breast Cancer Franchise of Novartis in Grand Rapids, Kalamazoo, Muskegon, Holland, Lansing, Traverse City, St Joseph, St Ignace and surrounding areas
• Growth and maintenance of Kisqali and Afinitor in a highly competitive metastatic breast cancer market
• Launch of 2 new indications for Kisqali in metastatic breast cancer market
• Collaborate with 2 partners and other Novartis personnel to service all the office's needs

• Top 1 or 2 in District sales goal achievement (to 25% of National Sales)
• Represent our district as the Liaison for Access and Reimbursement
• Represent the Genentech Avastin franchise in Oncology and Gynecology Oncology offices for mCRC (metastatic colorectal cancer) and psOC/prOC(ovarian cancers) and CC (cervical cancer)
• Collaborate with field partners and account stakeholders
• Growth and maintenance of Avastin as the market leader in mCRC in a highly competitive market
• Launch of 2 indications for Avastin in platinum sensitive and platinum resistant Ovarian Cancer
• Represent our team as the FOL-Field Operation Lead- which consists of computer, technology skills, sales results interpretation and pre-call planning
• Member of the Regions 'All-In Team', which included organizing activities around sales meetings and including activities that encouraged bonding among the region team members

• 2011 Highest National Team Champion Award
• 2008 Overall National Award Winner with a rank of 4th of 249 to win Highest Sales Award of 'Gold' which included an award trip to Australia
• Represent GSK Oncology in the Hematology/Oncology portfolio promoting Arzerra for CLL (Chronic Lymphocytic Leukemia) and Promacta for ITP (immune thrombocytopenia)
• Relationships with Western and Northern Michigan Oncology/Hematology offices
• Presented clinic contracts (Buy-And-Bill) including explanations of each program to customers
• Launch experience with 2 new products, including Arzerra (ofatumumab) for Chronic Lymphocytic Leukemia and Promacta (eltrombopag) for Immune (idiopathic) Thrombocytopenia
• Recognized for my ability in developing speakers/Key Opinion Leaders (KOL) for numerous disease state areas (CLL, ITP, and anticoagulation)
• Known for my local Oncology Nurse Society (ONS) meetings participation to network, learn, and play a role in helping provide speakers for this group

• 2005 Overall National Ranking - 53rd of 440
• Promoted anticoagulation and hospital portfolio of Arixtra, Argatroban, and Entereg to Oncology customers in clinic and hospital accounts
• Appointed to many field-based leadership positions/projects, including, National and Regional Trainer for Data Management (National), Monthly First Reports Launch (National), Expense Report Updates (Regional), Arixtra brand advisory board(Regional and National)
• Promoted GSK portfolio of products to clinics and hospitals in the therapeutic areas of Oncology, Pulmonology, Anesthesiology, Surgery, Emergency, and other critical care areas, including prepared presentations for contract discussions
• Appointed by manager for the following additional responsibilities: Data Management Advisory Board (2005, 2006), Arixtra Field Advisory Board (2006), Vice President's Advisory Board (2006, 2007)
• Appointed National and Regional Trainer for Data Management (National), Monthly First Reports Launch (National), Expense Report Updates (Regional), Arixtra brand (Regional and National)